NAFDAC alerts public to counterfeit cancer drug in circulation The National Agency for Food and Drug Administration and Control (NAFDAC) has issued an urgent warning about a suspected counterfeit cancer drug, Phesgo 600mg/600mg/10ml injection, identified by the batch number C5290S20. This warning follows a report from a doctor at Lagos University Teaching Hospital (LUTH) who raised concerns after a patient presented the drug for administration. An investigation revealed that this batch bore striking similarities to a previously flagged counterfeit batch, C3809C51. Roche, the legitimate manufacturer of Phesgo, examined images of the product...